2018 Dyspepsia Drug Development- Pipeline Analysis Report
Dyspepsia is a functional disorder affecting gastrointestinal tract and causes bloating, flatulence, heartburn, and diarrhea. Functional or idiopathic dyspepsia accounts for most of the Dyspepsia cases followed by Gastroduodenal ulcer disease and gastroesophageal reflux.
Around 20 companies and universities are focusing on developing treatment options for Dyspepsia.
To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Dyspepsia pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.
Current status, developmental phase, participating companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Dyspepsia pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.
In addition to complete details of each product, the report provides key trends in Dyspepsia pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
Around 20 companies and universities are focusing on developing treatment options for Dyspepsia.
To assist investigators and funding and regulatory organizations, VPA Research has come up with a comprehensive report on Dyspepsia pipeline. The report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.
Current status, developmental phase, participating companies and entities, recent developments, orphan drug/fast track/other designations, drug class are provided for each Dyspepsia pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.
In addition to complete details of each product, the report provides key trends in Dyspepsia pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.
1 TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2 DYSPEPSIA PIPELINE ANALYSIS
2.1 Disease and Pipeline Overview
2.2 Dyspepsia Pipeline Snapshot
2.3 Dyspepsia Pipeline by Phase
2.4 Dyspepsia Pipeline by Company
2.5 Dyspepsia Pipeline by Mechanism of Action
3 DYSPEPSIA- COMPANY WISE PIPELINE ANALYSIS
Abide Therapeutics
Daewoong Pharmaceutical Co Ltd
Dong-A ST Co., Ltd.
IlDong Pharmaceutical Co Ltd
LTT Bio-Pharma Co Ltd
RaQualia Pharma Inc
Renexxion LLC
Rottapharm
Zensun (Shanghai) Sci & Tech
Zeria Pharmaceutical Co Ltd
4 DYSPEPSIA R&D PIPELINE SNAPSHOTS
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details
5 RECENT DEVELOPMENTS IN DYSPEPSIA PIPELINE
6 APPENDIX
6.1 About VPA Research
6.2 Sources and Research Methodology
1.1 List of Figures
1.2 List of Tables
2 DYSPEPSIA PIPELINE ANALYSIS
2.1 Disease and Pipeline Overview
2.2 Dyspepsia Pipeline Snapshot
2.3 Dyspepsia Pipeline by Phase
2.4 Dyspepsia Pipeline by Company
2.5 Dyspepsia Pipeline by Mechanism of Action
3 DYSPEPSIA- COMPANY WISE PIPELINE ANALYSIS
Abide Therapeutics
Daewoong Pharmaceutical Co Ltd
Dong-A ST Co., Ltd.
IlDong Pharmaceutical Co Ltd
LTT Bio-Pharma Co Ltd
RaQualia Pharma Inc
Renexxion LLC
Rottapharm
Zensun (Shanghai) Sci & Tech
Zeria Pharmaceutical Co Ltd
4 DYSPEPSIA R&D PIPELINE SNAPSHOTS
Drug wise Pipeline Details
Therapeutic Candidate Name
Originator
Co-Developer/License Partner
Orphan Drug Designation
Development Phase
Mechanism of Action
Current Status
Ongoing Clinical Trial Details
5 RECENT DEVELOPMENTS IN DYSPEPSIA PIPELINE
6 APPENDIX
6.1 About VPA Research
6.2 Sources and Research Methodology
LIST OF FIGURES
Figure 1: Dyspepsia Pipeline by Phase, H1- 2018
Figure 2: Dyspepsia Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Dyspepsia Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018
Figure 1: Dyspepsia Pipeline by Phase, H1- 2018
Figure 2: Dyspepsia Pipeline by Companies, H1- 2018
Figure 3: Company Wise Pipeline Drug Phases, H1- 2018
Figure 4: Dyspepsia Pipeline by Mechanism of Action, H1- 2018
Figure 5: Mechanism Wise Pipeline Drug Phases, H1- 2018
LIST OF TABLES
Table 1: Dyspepsia Pipeline by Phase, H1- 2018
Table 2: Dyspepsia Pipeline by Companies, H1- 2018
Table 3: Dyspepsia Pipeline by Mechanism of Action, H1- 2018
Table 4: Abide Therapeutics Dyspepsia Pipeline, May 2018
Table 5: Daewoong Pharmaceutical Co Ltd Dyspepsia Pipeline, May 2018
Table 6: Dong-A ST Co., Ltd. Dyspepsia Pipeline, May 2018
Table 7: IlDong Pharmaceutical Co Ltd Dyspepsia Pipeline, May 2018
Table 8: LTT Bio-Pharma Co Ltd Dyspepsia Pipeline, May 2018
Table 9: RaQualia Pharma Inc Dyspepsia Pipeline, May 2018
Table 10: RaQualia Pharma Inc Dyspepsia Pipeline, May 2018
Table 11: Renexxion LLC Dyspepsia Pipeline, May 2018
Table 12: Rottapharm Dyspepsia Pipeline, May 2018
Table 13: Zensun (Shanghai) Sci & Tech Dyspepsia Pipeline, May 2018
Table 1: Dyspepsia Pipeline by Phase, H1- 2018
Table 2: Dyspepsia Pipeline by Companies, H1- 2018
Table 3: Dyspepsia Pipeline by Mechanism of Action, H1- 2018
Table 4: Abide Therapeutics Dyspepsia Pipeline, May 2018
Table 5: Daewoong Pharmaceutical Co Ltd Dyspepsia Pipeline, May 2018
Table 6: Dong-A ST Co., Ltd. Dyspepsia Pipeline, May 2018
Table 7: IlDong Pharmaceutical Co Ltd Dyspepsia Pipeline, May 2018
Table 8: LTT Bio-Pharma Co Ltd Dyspepsia Pipeline, May 2018
Table 9: RaQualia Pharma Inc Dyspepsia Pipeline, May 2018
Table 10: RaQualia Pharma Inc Dyspepsia Pipeline, May 2018
Table 11: Renexxion LLC Dyspepsia Pipeline, May 2018
Table 12: Rottapharm Dyspepsia Pipeline, May 2018
Table 13: Zensun (Shanghai) Sci & Tech Dyspepsia Pipeline, May 2018
